skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 2
Patent #:
NONE
Issue Dt:
Application #:
12440720
Filing Dt:
03/10/2009
Publication #:
Pub Dt:
11/12/2009
Inventors:
Taro Masuda, Osamu Nishimura, Katsuhiko Okumura, Noboru Okamura, Makoto Watanabe
Title:
TUMOR MARKER FOR RENAL CANCER AND METHOD FOR DETERMINATION OF OCCURRENCE OF RENAL CANCER
Assignment: 1
Reel/Frame:
022374/0506Recorded: 03/10/2009Pages: 3
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
02/19/2009
Exec Dt:
02/20/2009
Exec Dt:
02/16/2009
Exec Dt:
02/12/2009
Exec Dt:
02/20/2009
Assignees:
1, NISHINOKYO-KUWABARACHO, NAKAGYO-KU
KYOTO-SHI, KYOTO, JAPAN 604-8501
1-1, ROKKODAI-CHO, NADA-KU
KOBE-SHI, HYOGO, JAPAN 657-8501
Correspondent:
LEE CHENG
1100 17TH STREET N.W. STE 503
WASHINGTON, DC 20036
Assignment: 2
Reel/Frame:
022410/0224Recorded: 03/17/2009Pages: 5
Conveyance:
CORRECTIVE ASSIGNMENT TO CORRECT THE POSTAL CODE OF THE FIRST ASSIGNEE: FROM "604-8501" TO "604-8511" PREVIOUSLY RECORDED ON REEL 022374 FRAME 0506. ASSIGNOR(S) HEREBY CONFIRMS THE POSTAL CODE OF THE FIRST ASSIGNEE: "604-8511".
Assignors:
Exec Dt:
02/19/2009
Exec Dt:
02/20/2009
Exec Dt:
02/16/2009
Exec Dt:
02/12/2009
Exec Dt:
02/20/2009
Assignees:
1, NISHINOKYO-KUWABARACHO, NAKAGYO-KU
KYOTO-SHI, KYOTO, JAPAN 604-8511
1-1, ROKKODAI-CHO, NADA-KU
KOBE-SHI, HYOGO, JAPAN 657-8501
Correspondent:
LEE CHENG
1100 17TH STREET N.W. STE 503
WASHINGTON, DC 20036

Search Results as of: 04/27/2024 04:57 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT